Understanding rheumatic fever

Rheumatology International

Volumn 32, Issue 5, 2012, Pages 1113-1120

  Azevedo, Pedro Ming ^a   Pereira, Rosa Rodrigues ^a   Guilherme, Luiza ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Genetics; Immunology; Physiopathology; Rheumatic fever

Indexed keywords

CARDIAC MYOSIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FICOLIN; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; HLA DR7 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; LAMININ; MANNOSE BINDING LECTIN; TOLL LIKE RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA; TROPOMYOSIN; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA POLYMORPHISM; DOWN REGULATION; GENETIC SUSCEPTIBILITY; HUMAN; INNATE IMMUNITY; PRIORITY JOURNAL; REVIEW; RHEUMATIC FEVER; STREPTOCOCCUS PYOGENES;

ANIMALS; AUTOIMMUNITY; CYTOKINES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION MEDIATORS; PHENOTYPE; PROGNOSIS; RHEUMATIC FEVER; RISK FACTORS;

EID: 84863625273     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2152-z     Document Type: Review

References (56)

1. Hochberg MC (ed) (2003) Rheumatic fever. In: Rheumatology, vol 2, 3rd edn. Elsevier Health Sciences, New York, pp 1131-1141
2. Carapetis JR, Steer AC, Mulholland EK, Weber M (2005) The global burden of group A streptococcal diseases. Lancet Infect Dis 5(11):685-694
3. Ayoub EM (2001) Rheumatic fever. In: Rich RR (ed) Clinical immunology principles & practice, vol 2, 2nd edn. Mosby, St Louis, pp 1-7
4. Guilherme L, Kalil J (2004) Rheumatic fever: from sore throat to autoimmune heart lesions. Int Arch Allergy Immunol 134(1):56-64. doi:10.1159/000077915
5. Dajani AS, Ayoub E, Bierman FZ et al (1992) Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special writing Group of the Committee on rheumatic fever, endocarditis, and Kawasaki disease of the council on cardiovascular disease in the young of the American Heart Association. JAMA 268(15): 2069-2073
6. Carapetis JR, Currie BJ, Mathews JD (2000) Cumulative incidence of rheumatic fever in an endemic region: a guide to the susceptibility of the population? Epidemiol Infect 124(2):239-244
7. Guilherme L, Ramasawmy R, Kalil J (2007) Rheumatic fever and rheumatic heart disease: genetics and pathogenesis. Scand J Immunol 66(2-3):199-207
8. Gray F, Quinn R, WQuinn J (1952) A long term survey of rheumatic and non-rheumatic families; with particular reference to environment and heredity. Am J Med 13(4):400-412
9. Wilson MG, Schweitzer M (1954) Pattern of hereditary susceptibility in rheumatic fever. Circulation 10(5):699-704
10. Spagnuolo M, Taranta A (1968) Rheumatic fever in siblings. Similarity of its clinical manifestations. N Engl J Med 278(4):183-188
11. Guilherme L, Kalil J (2010) Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease. J Clin Immunol 30(1):17-23. doi:10.1007/s10875-009-9332-6
12. Guilherme L, Oshiro SE, Fae KC, Cunha-Neto E, Renesto G, Goldberg AC, Tanaka AC, Pomerantzeff PM, Kiss MH, Silva C, Guzman F, Patarroyo ME, Southwood S, Sette A, Kalil J (2001) T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients. Infect Immun 69(9):5345-5351
13. Messias Reason IJ, Schafranski MD, Jensenius JC, Steffensen R (2006) The association between mannose-binding lectin gene polymorphism and rheumatic heart disease. Hum Immunol 67(12):991-998. doi:10.1016/j.humimm.2006.08.296
14. Schafranski MD, Pereira Ferrari L, Scherner D, Torres R, Jensenius JC, de Messias-Reason IJ (2008) High-producing MBL2 genotypes increase the risk of acute and chronic carditis in patients with history of rheumatic fever. Mol Immunol 45(14):3827-3831. doi:10.1016/j.molimm.2008.05.013
15. Ramasawmy R, Spina GS, Fae KC, Pereira AC, Nisihara R, Messias Reason IJ, Grinberg M, Tarasoutchi F, Kalil J, Guil-herme L (2008) Association of mannose-binding lectin gene polymorphism but not of mannose-binding serine protease 2 with chronic severe aortic regurgitation of rheumatic etiology. Clin Vaccine Immunol 15(6):932-936. doi:10.1128/CVI.00324-07
16. Berdeli A, Celik HA, Ozyurek R, Dogrusoz B, Aydin HH (2005) TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children. J Mol Med 83(7): 535-541. doi:10.1007/s00109-005-0677-x
17. Messias-Reason IJ, Schafranski MD, Kremsner PG, Kun JF (2009) Ficolin 2 (FCN2) functional polymorphisms and the risk of rheumatic fever and rheumatic heart disease. Clin Exp Immunol 157(3):395-399. doi:10.1111/j.1365-2249.2009. 03975.x
18. Morris K, Mohan C, Wahi PL, Anand IS, Ganguly NK (1993) Enhancement of IL-1, IL-2 production and IL-2 receptor generation in patients with acute rheumatic fever and active rheumatic heart disease; a prospective study. Clin Exp Immunol 91(3):429-436
19. Hirsch E, Irikura V, Paul S, Hirsh D (1996) Functions of inter-leukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci 93:11008-11013
20. Danis VA, Millington M, Hyland VJ, Grennan D (1995) Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 99(2):303-310
21. Witkin SS, Gerber S, Ledger WJ (2002) Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 34(2):204-209
22. Yegin O, Coskun M, Ertug H (1997) Cytokines in acute rheumatic fever. Eur J Pediatr 156(1):25-29
23. Samsonov MY, Tilz GP, Pisklakov VP, Reibnegger G, Nassonov EL, Nassonova VA, Wachter H, Fuchs D (1995) Serum-soluble receptors for tumor necrosis factor-alpha and interleukin-2, and neopterin in acute rheumatic fever. Clin Immunol Immunopathol 74(1):31-34. doi:S0090122985710057
24. Narin N, Kutukculer N, Ozyurek R, Bakiler AR, Parlar A, Arcasoy M (1995) Lymphocyte subsets and plasma IL-1 alpha, IL-2, and TNF-alpha concentrations in acute rheumatic fever and chronic rheumatic heart disease. Clin Immunol Immunopathol 77(2):172-176
25. Fraser WJ, Haffejee Z, Jankelow D, Wadee A, Cooper K (1997) Rheumatic Aschoff nodules revisited. II: cytokine expression corroborates recently proposed sequential stages. Histopathology 31(5):460-464
26. Chou HT, Chen CH, Tsai CH, Tsai FJ (2004) Association between transforming growth factor-beta1 gene C-509T and T869C polymorphisms and rheumatic heart disease. Am Heart J 148(1):181-186. doi:10.1016/j.ahj.2004.03. 032
27. Duzgun N, Duman T, Haydardedeoglu FE, Tutkak H (2009) Cytotoxic T lymphocyte-associated antigen-4 polymorphism in patients with rheumatic heart disease. Tissue Antigens 74(6): 539-542. doi:10.1111/j.1399-0039.2009.01347.x
28. Cunningham MW (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13(3):470-511
29. Cunningham MW, McCormack JM, Fenderson PG, Ho MK, Beachey EH, Dale JB (1989) Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein. J Immunol 143(8):2677-2683
30. Cunningham MW (2004) T cell mimicry in inflammatory heart disease. Mol Immunol 40(14-15):1121-1127. doi:10.1016/j.molimm.2003.11.023
31. Kirvan CA, Swedo SE, Heuser JS, Cunningham MW (2003) Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 9(7):914-920. doi:10.1038/nm892
32. Roberts S, Kosanke S, Terrence Dunn S, Jankelow D, Duran CM, Cunningham MW (2001) Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium. J Infect Dis 183(3): 507-511. doi:10.1086/318076
33. Galvin JE, Hemric ME, Ward K, Cunningham MW (2000) Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. J Clin Invest 106(2):217-224. doi:10.1172/JCI7132
34. Guilherme L, Weidebach W, Kiss MH, Snitcowsky R, Kalil J (1991) Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population. Circulation 83(6):1995-1998
35. Kemeny E, Grieve T, Marcus R, Sareli P, Zabriskie JB (1989) Identification of mononuclear cells and T cell subsets in rheumatic valvulitis. Clin Immunol Immunopathol 52(2):225-237
36. Raizada V, Williams RC Jr, Chopra P, Gopinath N, Prakash K, Sharma KB, Cherian KM, Panday S, Arora R, Nigam M, Zabriskie JB, Husby G (1983) Tissue distribution of lymphocytes in rheumatic heart valves as defined by monoclonal anti-T cell antibodies. Am J Med 74(1):90-96
37. Fae KC, da Silva DD, Oshiro SE, Tanaka AC, Pomerantzeff PM, Douay C, Charron D, Toubert A, Cunningham MW, Kalil J, Guilherme L (2006) Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease. J Immunol 176(9):5662-5670. doi:176/9/5662
38. Yoshinaga M, Figueroa F, Wahid MR, Marcus RH, Suh E, Zabriskie JB (1995) Antigenic specificity of lymphocytes isolated from valvular specimens of rheumatic fever patients. J Autoim-mun 8(4):601-613. doi:0896-8411(95)90011-X
39. Ellis NM, Li Y, Hildebrand W, Fischetti VA, Cunningham MW (2005) T cell mimicry and epitope specificity of cross-reactive T cell clones from rheumatic heart disease. J Immunol 175(8): 5448-5456. doi:175/8/5448
40. Guilherme L, Dulphy N, Douay C, Coelho V, Cunha-Neto E, Oshiro SE, Assis RV, Tanaka AC, Pomerantzeff PM, Charron D, Toubert A, Kalil J (2000) Molecular evidence for antigen-driven immune responses in cardiac lesions of rheumatic heart disease patients. Int Immunol 12(7):1063-1074
41. Wucherpfennig KW, Allen PM, Celada F, Cohen IR, De Boer R, Garcia KC, Goldstein B, Greenspan R, Hafler D, Hodgkin P, Huseby ES, Krakauer DC, Nemazee D, Perelson AS, Pinilla C, Strong RK, Sercarz EE (2007) Polyspecificity of T cell and B cell receptor recognition. Semin Immunol 19(4):216-224. doi: 10.1016/j.smim.2007.02.012
42. Fae K, Kalil J, Toubert A, Guilherme L (2004) Heart infiltrating T cell clones from a rheumatic heart disease patient display a common TCR usage and a degenerate antigen recognition pattern. Mol Immunol 40(14-15):1129-1135. doi:10.1016/j.molimm. 2003.11.007
43. Lehmann PV, Forsthuber T, Miller A, Sercarz EE (1992) Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358(6382):155-157. doi:10.1038/358155a0
44. Read SE, Reid HF, Fischetti VA, Poon-King T, Ramkissoon R, McDowell M, Zabriskie JB (1986) Serial studies on the cellular immune response to streptococcal antigens in acute and convalescent rheumatic fever patients in Trinidad. J Clin Immunol 6(6):433-441
45. Guilherme L, Cury P, Demarchi LM, Coelho V, Abel L, Lopez AP, Oshiro SE, Aliotti S, Cunha-Neto E, Pomerantzeff PM, Ta-naka AC, Kalil J (2004) Rheumatic heart disease: proinflamma-tory cytokines play a role in the progression and maintenance of valvular lesions. Am J Pathol 165(5):1583-1591. doi:165/5/1583
46. Azevedo PM, Bauer R, Caparbo Vde F, Silva CA, Bonfa E, Pereira RM (2010) Interleukin-1 receptor antagonist gene (IL1RN) polymorphism possibly associated to severity of rheumatic carditis in a Brazilian cohort. Cytokine 49(1):109-113. doi: 10.1016/j.cyto.2009.09.003
47. Granowitz EV, Santos AA, Poutsiaka DD, Cannon JG, Wilmore DW, Wolff SM, Dinarello CA (1991) Production of interleukin-1-receptor antagonist during experimental endotoxaemia. Lancet 338(8780):1423-1424. doi:0140-6736(91)92725-H
48. Kamal H, Hussein G, Hassoba H, Mosaad N, Gad A, Ismail M (2010) Transforming growth factor-beta1 gene C-509T and T869C polymorphisms as possible risk factors in rheumatic heart disease in Egypt. Acta Cardiol 65(2):177-183
49. Settin A, Abdel-Hady H, El-Baz R, Saber I (2007) Gene polymorphisms of TNF-alpha(-308), IL-10 (-1082), IL-6 (-174), and IL-1Ra (VNTR) related to susceptibility and severity of rheumatic heart disease. Pediatr Cardiol 28(5):363-371
50. Berdeli A, Celik HA, Ozyurek R, Aydin HH (2004) Involvement of immunoglobulin FcgammaRIIA and FcgammaRIIIB gene polymorphisms in susceptibility to rheumatic fever. Clin Bio-chem 37(10):925-929. doi:10.1016/j.clinbiochem. 2004.06.007
51. Ramasawmy R, Fae KC, Spina G, Victora GD, Tanaka AC, Palacios SA, Hounie AG, Miguel EC, Oshiro SE, Goldberg AC, Kalil J, Guilherme L (2007) Association of polymorphisms within the promoter region of the tumor necrosis factor-alpha with clinical outcomes of rheumatic fever. Mol Immunol 44(8):1873-1878. doi:10.1016/j.molimm.2006.10.001
52. Sallakci N, Akcurin G, Koksoy S, Kardelen F, Uguz A, Coskun M, Ertug H, Yegin O (2005) TNF-alpha G-308A polymorphism is associated with rheumatic fever and correlates with increased TNF-alpha production. J Autoimmun 25(2):150-154. doi: 10.1016/j.jaut.2005.05.005
53. Hernandez-Pacheco G, Flores-Dominguez C, Rodriguez-Perez JM, Perez-Hernandez N, Fragoso JM, Saul A, Alvarez-Leon E, Granados J, Reyes PA, Vargas-Alarcon G (2003) Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with rheumatic heart disease. J Autoimmun 21(1):59-63. doi:S089 6841103000799
54. Hounie AG, Cappi C, Cordeiro Q, Sampaio AS, Moraes I, Rosario MC, Palacios SA, Goldberg AC, Vallada HP, Machado-Lima A, Nakano E, Kalil J, Pauls D, Pereira CA, Guilherme L, Miguel EC (2008) TNF-alpha polymorphisms are associated with obsessive-compulsive disorder. Neurosci Lett 442(2):86-90. doi: 10.1016/j.neulet.2008.07.022
55. Davutoglu V, Nacak M (2005) Influence of angiotensin-con-verting enzyme gene insertion/deletion polymorphism on rheumatic valve involvement, valve severity and subsequent valve calcification. J Heart Valve Dis 14(3):277-281
56. Chou HT, Tsai CH, Tsai FJ (2004) Association between angio-tensin I-converting enzyme gene insertion/deletion polymorphism and risk of rheumatic heart disease. Jpn Heart J 45(6):949-957. doi:JST.JSTAGE/jhj/45.949